Skip to main content
Equibles
CYH logo

CYH · Community Health Systems Inc · Metrics

Track CYH — free

Use CYH with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CYH.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.92 +0.03 (+1.04%) At close · Sep 11
Russell 2000 member Rebalance outlook locked
Market Cap
$411.75M
Shares
141.01M

CYH metrics

80 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$2.92
Market cap
$411.75M

Price action

20 metrics
Price change (1W)
+1.0%
Price change (30D)
-1.7%
Price change (3M)
-6.4%
Price change (6M)
-8.8%
Price change (YTD)
-6.4%
Price change (1Y)
-2.7%
Trailing year
Price change (5Y)
-74.2%
52-week high
$4.41
52-week low
$2.49
Change from 52-week high
-33.8%
Change from 52-week low
+17.3%
Annualized volatility
56.5%
Annualized volatility (3M)
56.0%
Beta
1.3
RSI (14D)
48.1
Price vs SMA 50
-4.5%
Price vs SMA 200
-6.3%
Avg volume (3M)
1.63M
Relative volume
0.5
Average dollar volume
$5.04M

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
141.01M

Valuation

12 metrics
P / E (TTM)
1.6
Trailing earnings · reciprocal yield 63.7%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.0×
reciprocal yield 2,910.3%
P / book
—
FCF yield
-44.9%
TTM · current market cap
Buyback yield
6.6%
P / FCF
—
P / operating cash flow
3.3
reciprocal yield 30.6%
Earnings yield
61.2%

Historical valuation

8 metrics
P / E historical average (3Y)
1.4×
reciprocal yield 70.9%
P / E historical average (5Y)
4.6×
reciprocal yield 22.0%
EV / revenue historical average (3Y)
0.9×
reciprocal yield 109.9%
EV / revenue historical average (5Y)
0.9×
reciprocal yield 105.3%
EV / EBIT historical average (3Y)
12.9×
reciprocal yield 7.7%
EV / EBIT historical average (5Y)
12.3×
reciprocal yield 8.1%
EV / EBITDA historical average (3Y)
8.2×
reciprocal yield 12.3%
EV / EBITDA historical average (5Y)
7.9×
reciprocal yield 12.6%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
6.6%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-23

Profitability

9 metrics
Gross margin
85.4%
Operating margin
11.4%
Trailing 12 months
Net margin
2.1%
Gross profit (TTM)
—
Operating profit (TTM)
$1.36B
Net income (TTM)
$252.00M
Trailing 12 months
Diluted EPS (TTM)
$1.86
FCF margin
-1.5%
Effective tax rate
11.4%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-10.06

Growth

11 metrics
Revenue growth YoY
-9.8%
Year over year
Net income growth YoY
-75.2%
Revenue (TTM)
$11.98B
Trailing 12 months
EPS growth YoY
-75.6%
Shares change YoY
+1.2%
Year over year · more shares
Revenue CAGR (3Y)
+0.7%
Revenue CAGR (5Y)
+1.2%
EPS CAGR (3Y)
+120.8%
EPS CAGR (5Y)
-3.0%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
-34.6%

Quality

14 metrics
Return on equity
—
Return on assets
2.1%
Debt / equity
—
Current ratio
1.5
EBITDA (TTM)
$1.80B
Free cash flow (TTM)
−$185.00M
Quick ratio
1.5
Interest coverage
1.6
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$149.00M
Total assets
$12.18B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$126.00M
Capital expenditures (TTM)
$311.00M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$9.00M
R&D / revenue
—
Stock compensation / revenue
0.1%

Ownership (13F)

3 metrics
13F filers
183
13F filer change QoQ
+5
Institutional ownership
83.0%

Short interest

3 metrics
Short interest
9.3%
Latest settlement · 12.7 days to cover
Days to cover
12.7d
Short-squeeze score
72 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$118,400
Insider-sentiment score
46 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1108109 CUSIP 203668108 13F (30d) 61 filings 61 filers Visit website Investor relations